I'm a triple board-certified psychiatrist working at the intersection of clinical care, executive leadership, and systems-level innovation in mental health.

My career has evolved from traditional clinical practice into three distinct but complementary roles: Chief Medical Officer of Enterhealth, Medical Director of The Noesis Clinic, and Clinical Associate Professor at Texas A&M School of Medicine. These positions allow me to influence mental health care at multiple scales—from individual patients to organizational systems to the broader field of psychiatry.

What connects these roles is a commitment to what I call Psychiatry 3.0: an approach that integrates neuroscience, systems biology, and personalized medicine while maintaining rigorous evidence-based standards. This framework recognizes that effective psychiatric care requires understanding not just brain chemistry, but also inflammation, metabolism, genetics, trauma, and the social determinants of mental health.

I've spent nearly two decades building clinical programs focused on populations that traditional psychiatry often struggles to serve effectively: veterans and active-duty service members, older adults facing cognitive decline, and individuals with complex addiction and co-occurring disorders. This work has reinforced my belief that the future of psychiatry lies in bridging the gap between conventional treatment and functional medicine approaches.

CURRENT ROLES

  • Chief Medical Officer, Enterhealth

Leading clinical strategy and innovation for premier residential and outpatient substance use and mental health treatment across North Texas.

  • Medical Director, The Noesis Clinic

Private practice in adult and geriatric psychiatry, specializing in evidence-based dementia care, TMS therapy, and treatment-resistant conditions.

  • Clinical Associate Professor, Texas A&M School of Medicine

Mentoring medical students in psychiatric practice and contributing to the education of the next generation of physicians.

  • Advanced Brain Health Initiative [In Development]

Building a concierge psychiatry service focused on cognitive risk assessment, functional psychiatry, and early detection of neurodegenerative conditions. Launching Q2 2025.

  • In addition to clinical and academic roles, I serve in national nonprofit leadership focused on advancing mental health access, resilience, and systems-level care.

    Vice Chair, PsychArmor

    National nonprofit providing critical resources to Americans so they can effectively engage with and support military service members, veterans, and their families.

    Member Scientific Advisory Board, (ex-Chair) The Headstrong Project

    National mental health organization providing confidential, barrier-free, stigma-free PTSD treatment to veterans, service members, and military families.

    George W. Bush Institute Stand-To Veteran Leadership Program Scholar

    Selected as Class of 2021 Scholar for leadership in advancing veteran mental health care.

    Expert Panelist, Texas Medical Board

    Appointed member assisting in investigations and disciplinary hearings related to the Medical Practice Act.

  • Board Certifications

    • American Board of Psychiatry & Neurology - General Psychiatry

    • American Board of Psychiatry & Neurology - Geriatric Psychiatry

    • American Board of Preventive Medicine - Addiction Medicine

    Distinguished Fellow

    American Psychiatric Association (DFAPA)

    Advanced Training

    • Fellowship in Geriatric Psychiatry - UT Southwestern Medical Center

    • Fellowship in Integrative & Functional Psychiatry - Psychiatry Redefined

    • Psychiatry Residency - Wayne State University

    Executive Education

    • Executive Healthcare Leadership - Cornell University

    • Effective Writing for Healthcare (Public Health) - Harvard Medical School

  • The evolution of psychiatric care can be understood in three phases:

    Psychiatry 1.0 focused on psychoanalysis and talk therapy without a strong biological foundation.

    Psychiatry 2.0 introduced neurotransmitter-based treatments—SSRIs, antipsychotics, and evidence-based psychotherapy. This is where most of the field remains today.

    Psychiatry 3.0 integrates circuit-based neuroscience, systems biology, and personalized medicine. It asks not just "Which neurotransmitter is dysregulated?" but "What underlying systems are driving this dysregulation?" This includes inflammation, gut-brain axis dysfunction, metabolic disturbances, genetic vulnerabilities, and psychosocial stressors.

    This framework informs all my work—from building addiction treatment systems at Enterhealth, to managing complex geriatric cases at The Noesis Clinic, to developing advanced brain health protocols for high-performing executives.

    The goal is not to replace evidence-based psychiatry, but to expand it. Read more on my blog here.